Literature DB >> 12441140

IL-4, but not IL-13, modulates TARC (thymus and activation-regulated chemokine)/CCL17 and IP-10 (interferon-induced protein of 10kDA)/CXCL10 release by TNF-alpha and IFN-gamma in HaCaT cell line.

Takashi Kakinuma1, Koichiro Nakamura, Motoshi Wakugawa, Shoichiro Yano, Hidehisa Saeki, Hideshi Torii, Mayumi Komine, Akihiko Asahina, Kunihiko Tamaki.   

Abstract

It is known that both interleukin-4 (IL-4) and IL-13 are produced by Th2-type cells and share similar biological functions with each other. However, recently accumulated evidences have revealed that IL-4 may be involved in the Th1-type response. Both thymus and activation-regulated chemokine (TARC/CCL17), a ligand for CC chemokine receptor 4 that is mainly expressed on Th2-type cells, and interferon-induced protein of 10kDa (IP-10/CXCL10), a ligand for CXC chemokine receptor 3 that is mainly expressed on Th1-type cells, are produced by keratinocytes after the stimulation with the primary cytokines such as tumor necrotic factor-alpha (TNF-alpha) and/or interferon-gamma (IFN-gamma). In this study, we investigated the regulation of TARC or IP-10 production from HaCaT cells, an immortalized human keratinocyte cell line, after stimulation with TNF-alpha, IFN-gamma, IL-4 and/or IL-13. Without stimulation, HaCaT cells did not produce TARC. When both TNF-alpha and IFN-gamma were added, they increased synergistically (P<0.003). In addition, when HaCaT cells were stimulated with IL-4, but not IL-13, in combination with TNF-alpha and IFN-gamma, the supernatant TARC levels significantly decreased compared to those with both TNF-alpha and IFN-gamma (P<0.009). This inhibition was completely abolished with the addition of neutralizing anti-IL-4 antibody. The supernatant IP-10 levels also increased synergistically by stimulation with TNF-alpha and IFN-gamma for 24h (P<0.001). When IL-4, but not IL-13, was added to the medium and the cells were co-cultured with these cytokines, the IP-10 levels significantly increased compared to those with both TNF-alpha and IFN-gamma (P<0.04). Furthermore, the effects of IL-4 on TARC and IP-10 production in these cells were detected in a dose-dependent manner. These data strongly suggest that IL-4 may act not only as a mediator of Th1-type response but also as a down-regulator of Th2-type response in terms of the regulation of chemokine production by HaCaT cells.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12441140     DOI: 10.1006/cyto.2002.1965

Source DB:  PubMed          Journal:  Cytokine        ISSN: 1043-4666            Impact factor:   3.861


  7 in total

1.  Interleukin-4 and interleukin-13 enhance CCL26 production in a human keratinocyte cell line, HaCaT cells.

Authors:  S Kagami; H Saeki; M Komine; T Kakinuma; Y Tsunemi; K Nakamura; K Sasaki; A Asahina; K Tamaki
Journal:  Clin Exp Immunol       Date:  2005-09       Impact factor: 4.330

2.  IL-4 induces expression of TARC/CCL17 via two STAT6 binding sites.

Authors:  Gerald Wirnsberger; Daniel Hebenstreit; Gernot Posselt; Jutta Horejs-Hoeck; Albert Duschl
Journal:  Eur J Immunol       Date:  2006-07       Impact factor: 5.532

Review 3.  What does elevated TARC/CCL17 expression tell us about eosinophilic disorders?

Authors:  Julien Catherine; Florence Roufosse
Journal:  Semin Immunopathol       Date:  2021-05-19       Impact factor: 9.623

4.  Optimization of Cytokine Milieu to Reproduce Atopic Dermatitis-related Gene Expression in HaCaT Keratinocyte Cell Line.

Authors:  Hee Joo Kim; Jinok Baek; Jong Rok Lee; Joo Young Roh; YunJae Jung
Journal:  Immune Netw       Date:  2018-02-13       Impact factor: 6.303

5.  Differences in itch and pain behaviors accompanying the irritant and allergic contact dermatitis produced by a contact allergen in mice.

Authors:  Zhe Zhang; Nathalie M Malewicz; Xiaoyun Xu; Jianhao Pan; Nina Kumowski; Tao Zhu; Steven G Shimada; Hong Nie; Robert H LaMotte
Journal:  Pain Rep       Date:  2019-09-11

6.  Group 2 Innate Lymphoid Cells Express Functional NKp30 Receptor Inducing Type 2 Cytokine Production.

Authors:  Maryam Salimi; Luzheng Xue; Helen Jolin; Clare Hardman; David J Cousins; Andrew N J McKenzie; Graham S Ogg
Journal:  J Immunol       Date:  2015-11-18       Impact factor: 5.422

7.  Medium dose ultraviolet A1 phototherapy and mRNA expression of interleukin 8, interferon γ, and chemokine receptor 4 in acute skin lesions in atopic dermatitis.

Authors:  Jarosław Bogaczewicz; Karolina Malinowska; Anna Sysa-Jedrzejowska; Anna Wozniacka
Journal:  Postepy Dermatol Alergol       Date:  2016-06-17       Impact factor: 1.837

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.